Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function

Adenosine regulates a wide variety of physiological processes via interaction with one or more G‐protein‐coupled receptors (A1R, A2AR A2BR and A3R). Because A1R occupancy promotes fusion of human monocytes to form giant cells in vitro, we determined whether A1R occupancy similarly promotes osteoclast function and formation. Bone marrow cells (BMCs) were harvested from C57Bl/6 female mice or A1R‐knockout mice and their wild‐type (WT) littermates and differentiated into osteoclasts in the presence of colony stimulating factor‐1 and receptor activator of NF‐κB ligand in the presence or absence of the A1R antagonist 1,3‐dipropyl‐8‐cyclopentyl xanthine (DPCPX). Osteoclast morphology was analyzed in tartrate‐resistant acid phosphatase or F‐actin‐stained samples, and bone resorption was evaluated by toluidine blue staining of dentin. BMCs from A1R‐knockout mice form fewer osteoclasts than BMCs from WT mice, and the A1R antagonist DPCPX inhibits osteoclast formation (IC50=1 nM), with altered morphology and reduced ability to resorb bone. A1R blockade increased ubiquitination and degradation of TRAF6 in RAW264.7 cells induced to differentiate into osteoclasts. These studies suggest a critical role for adenosine in bone homeostasis via interaction with adenosine A1R and further suggest that A1R may be a novel pharmacologic target to prevent the bone loss associated with inflammatory diseases and menopause.—Kara, F. M., Chitu, V., Sloane, J., Axelrod, M., Fredholm, B. B., Stanley, R, Cronstein, B. N. Adenosine A1 receptors (A1Rs) play a critical role in osteoclast formation and function. FASEB J. 24, 2325–2333 (2010). www.fasebj.org

[1]  E. Lewiecki,et al.  Osteoporosis , 2011, Annals of Internal Medicine.

[2]  B. Fredholm,et al.  Adenosine A(1) receptors regulate bone resorption in mice: adenosine A(1) receptor blockade or deletion increases bone density and prevents ovariectomy-induced bone loss in adenosine A(1) receptor-knockout mice. , 2010, Arthritis and rheumatism.

[3]  R. Berne,et al.  Effects of hypoxia and ischaemia on coronary vascular resistance, A-V node conduction and S-A node excitation. , 2009, Acta medica Scandinavica. Supplementum.

[4]  L. Chiriboga,et al.  Amendment history : Corrigendum ( April 2009 ) Adenosine signaling contributes to ethanol-induced fatty liver in mice , 2018 .

[5]  U. Lerner,et al.  Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-{kappa}B and c-Fms. , 2007, The Journal of endocrinology.

[6]  Linda Yip,et al.  ATP Release Guides Neutrophil Chemotaxis via P2Y2 and A3 Receptors , 2006, Science.

[7]  M. Postow,et al.  Tumor Necrosis Factor-α Prevents Desensitization of Gαs-Coupled Receptors by Regulating GRK2 Association with the Plasma Membrane , 2006, Molecular Pharmacology.

[8]  R. Neubig,et al.  Endogenous RGS Proteins and G&agr; Subtypes Differentially Control Muscarinic and Adenosine-Mediated Chronotropic Effects , 2006, Circulation research.

[9]  C. Elford,et al.  Human Osteoblast Precursors Produce Extracellular Adenosine, Which Modulates Their Secretion of IL‐6 and Osteoprotegerin , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  D. Larson,et al.  The PCH family member MAYP/PSTPIP2 directly regulates F-actin bundling and enhances filopodia formation and motility in macrophages. , 2005, Molecular biology of the cell.

[11]  W. Swat,et al.  Vav3 regulates osteoclast function and bone mass , 2005, Nature Medicine.

[12]  Y. Wong,et al.  G16-mediated Activation of Nuclear Factor κB by the Adenosine A1 Receptor Involves c-Src, Protein Kinase C, and ERK Signaling* , 2004, Journal of Biological Chemistry.

[13]  F. Saltel,et al.  Apatite-mediated actin dynamics in resorbing osteoclasts. , 2004, Molecular biology of the cell.

[14]  Darrell R. Abernethy,et al.  International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels , 2003, Pharmacological Reviews.

[15]  B. Cronstein,et al.  Th1 Cytokines Regulate Adenosine Receptors and Their Downstream Signaling Elements in Human Microvascular Endothelial Cells 1 , 2003, The Journal of Immunology.

[16]  L. Pott,et al.  G Protein‐Independent Inhibition of GIRK Current by Adenosine in Rat Atrial Myocytes Overexpressing A1 Receptors after Adenovirus‐Mediated Gene Transfer , 2003, The Journal of physiology.

[17]  S. M. Sims,et al.  Regulation of Osteoclasts by Calcitonin and Amphiphilic Calcitonin Conjugates: Role of Cytosolic Calcium , 2003, Calcified Tissue International.

[18]  Hong-Hee Kim,et al.  Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. , 2003, Biochemical and biophysical research communications.

[19]  E. Wagner,et al.  Reaching a genetic and molecular understanding of skeletal development. , 2002, Developmental cell.

[20]  R. Ye Regulation of nuclear factor κB activation by G‐protein‐coupled receptors , 2001, Journal of leukocyte biology.

[21]  B. Fredholm,et al.  International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. , 2001, Pharmacological reviews.

[22]  B. Cronstein,et al.  Inflammatory Cytokines Regulate Function and Expression of Adenosine A2A Receptors in Human Monocytic THP-1 Cells1 , 2001, The Journal of Immunology.

[23]  B. Fredholm,et al.  Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Dianqing Wu,et al.  Gα16 Couples Chemoattractant Receptors to NF-κB Activation1 , 2001, The Journal of Immunology.

[25]  S. Dixon,et al.  Osteoclast ion channels: potential targets for antiresorptive drugs. , 2001, Current pharmaceutical design.

[26]  M. Si-Tahar,et al.  Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6. , 2001, The Journal of clinical investigation.

[27]  M. Nomura,et al.  Effect of γ‐butyrobetaine on fatty liver in juvenile visceral steatosis mice , 2001 .

[28]  S. Teitelbaum,et al.  Bone resorption by osteoclasts. , 2000, Science.

[29]  T. Martin,et al.  Therapeutic approaches to bone diseases. , 2000, Science.

[30]  Wyeth Wasserman,et al.  Structure and function of adenosine receptors and their genes , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[31]  S. M. Sims,et al.  Electrophysiological characterization of ion channels in osteoclasts isolated from human deciduous teeth. , 2000, Bone.

[32]  S. Manolagas,et al.  Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. , 2000, Endocrine reviews.

[33]  S. Morham,et al.  Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. , 2000, The Journal of clinical investigation.

[34]  C. Gatlin,et al.  TGF-beta enhances osteoclast differentiation in hematopoietic cell cultures stimulated with RANKL and M-CSF. , 1999, Biochemical and biophysical research communications.

[35]  C. Gay,et al.  Depolarization of Osteoclast Plasma Membrane Potential by 17β‐Estradiol , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  N. Udagawa,et al.  A novel molecular mechanism modulating osteoclast differentiation and function. , 1999, Bone.

[37]  Sakae Tanaka,et al.  Severe osteopetrosis, defective interleukin‐1 signalling and lymph node organogenesis in TRAF6‐deficient mice , 1999, Genes to cells : devoted to molecular & cellular mechanisms.

[38]  T. Martin,et al.  Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. , 1999, Endocrine reviews.

[39]  S. Morony,et al.  TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. , 1999, Genes & development.

[40]  T. Chambers,et al.  Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. , 1999, Endocrinology.

[41]  R. Steinman,et al.  The TRAF Family of Signal Transducers Mediates NF-κB Activation by the TRANCE Receptor* , 1998, The Journal of Biological Chemistry.

[42]  C. Taylor,et al.  Neutrophil-derived 5′-Adenosine Monophosphate Promotes Endothelial Barrier Function via CD73-mediated Conversion to Adenosine and Endothelial A2B Receptor Activation , 1998, The Journal of experimental medicine.

[43]  G. Daculsi,et al.  Cytokines, growth factors and osteoclasts. , 1998, Cytokine.

[44]  B. Cronstein,et al.  Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides. , 1998, The Journal of clinical investigation.

[45]  Ulrich Siebenlist,et al.  Requirement for NF-κB in osteoclast and B-cell development , 1997 .

[46]  G. Burnstock,et al.  Purinergic transmitters inhibit bone formation by cultured osteoblasts. , 1997, Bone.

[47]  S. M. Sims,et al.  Extracellular Nucleotides Activate non‐Selective Cation and Ca2+‐Dependent K+ Channels in Rat Osteoclasts , 1997, The Journal of physiology.

[48]  J. Blay,et al.  The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine. , 1997, Cancer research.

[49]  L. Aiello,et al.  Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells. , 1996, Investigative ophthalmology & visual science.

[50]  R. Baron Molecular mechanisms of bone resorption. An update. , 1995, Acta orthopaedica Scandinavica. Supplementum.

[51]  M Horton,et al.  The osteoclast clear zone is a specialized cell-extracellular matrix adhesion structure. , 1995, Journal of cell science.

[52]  I. Owan,et al.  Postmitotic osteoclast precursors are mononuclear cells which express macrophage-associated phenotypes. , 1994, Developmental biology.

[53]  N. Standen,et al.  Adenosine‐activated potassium current in smooth muscle cells isolated from the pig coronary artery. , 1993, The Journal of physiology.

[54]  M. Noble,et al.  Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Mrsny,et al.  5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. , 1993, The Journal of clinical investigation.

[56]  M. Zaidi,et al.  Regulation of cytosolic free calcium in isolated rat osteoclasts by calcitonin. , 1992, The Journal of endocrinology.

[57]  K. Väänänen,et al.  Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro , 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[58]  M. Simon,et al.  G alpha 16, a G protein alpha subunit specifically expressed in hematopoietic cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Schrader,et al.  Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine. , 1991, Circulation research.

[60]  T. Dunwiddie,et al.  Adenosine A1 receptors inhibit adenylate cyclase activity and neurotransmitter release and hyperpolarize pyramidal neurons in rat hippocampus. , 1989, The Journal of pharmacology and experimental therapeutics.

[61]  H. Granger,et al.  Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. , 1988, The American journal of physiology.

[62]  Martin J. Lohse,et al.  8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) — a selective high affinity antagonist radioligand for A1 adenosine receptors , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[63]  J. Schrader,et al.  Contribution of coronary endothelial cells to cardiac adenosine production , 1986, Pflügers Archiv.

[64]  J. Pearson,et al.  Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides , 1979, Nature.

[65]  A. Malik,et al.  G alpha 16 couples chemoattractant receptors to NF-kappa B activation. , 2001, Journal of immunology.

[66]  T. Taniguchi,et al.  T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. , 2000, Nature.

[67]  W. Ho,et al.  Modulation of ATP-sensitive K+ channels in rabbit ventricular myocytes by adenosine A1 receptor activation. , 1997, The American journal of physiology.

[68]  A. Leonardi,et al.  Requirement for NF-kappaB in osteoclast and B-cell development. , 1997, Genes & development.

[69]  B. Cronstein,et al.  Adenosine A1 receptor promotion of multinucleated giant cell formation by human monocytes: a mechanism for methotrexate-induced nodulosis in rheumatoid arthritis. , 1997, Arthritis and rheumatism.

[70]  A. Tucker,et al.  Cloned receptors and cardiovascular responses to adenosine. , 1993, Cardiovascular research.